Literature DB >> 23036669

The high cost of cancer drugs and what we can do about it.

Mustaqeem Siddiqui1, S Vincent Rajkumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23036669      PMCID： PMC3538397          DOI： 10.1016/j.mayocp.2012.07.007

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  39 in total

1.  Years of healthy life.

Authors:  P Erickson; R Wilson; I Shannon
Journal:  Healthy People 2000 Stat Notes       Date:  1995-04

2.  The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology.

Authors:  Amy E McKee; Ann T Farrell; Richard Pazdur; Janet Woodcock
Journal:  Oncologist       Date:  2010

3.  Calculating QALYs, comparing QALY and DALY calculations.

Authors:  Franco Sassi
Journal:  Health Policy Plan       Date:  2006-07-28       Impact factor: 3.344

4.  Emerging lessons from the drug effectiveness review project.

Authors:  Peter J Neumann
Journal:  Health Aff (Millwood)       Date:  2006-06-06       Impact factor: 6.301

5.  Benefit design and specialty drug use.

Authors:  Dana P Goldman; Geoffrey F Joyce; Grant Lawless; William H Crown; Vincent Willey
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

6.  Does reimbursement influence chemotherapy treatment for cancer patients?

Authors:  Mireille Jacobson; A James O'Malley; Craig C Earle; Juliana Pakes; Peter Gaccione; Joseph P Newhouse
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

7.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

8.  An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.

Authors:  Chris P Lee; Glenn M Chertow; Stefanos A Zenios
Journal:  Value Health       Date:  2009 Jan-Feb       Impact factor: 5.725

9.  The Landscape for Pharmaceutical Innovation: Drivers of Cost-Effective Clinical Research.

Authors:  Kenneth I Kaitin
Journal:  Pharm Outsourcing       Date:  2010-05

Review 10.  Off-label use of anticancer drugs.

Authors:  Dominique Levêque
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316
View more
  58 in total

Review 1.  Accountable care organizations and the practice of oncology.

Authors:  Steven J Bernstein
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

2.  Variation of Cost among Anti-cancer Drugs Available in Indian Market.

Authors:  Bhanu Prakash Kolasani; Divyashanthi Chellathambi Malathi; Raghunatha Rao Ponnaluri
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  Integrating value assessment into discussions about the price of cancer drugs.

Authors:  Craig Bunnell
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

Review 4.  Next-generation multiple myeloma treatment: a pharmacoeconomic perspective.

Authors:  S Vincent Rajkumar; Jean Luc Harousseau
Journal:  Blood       Date:  2016-10-14       Impact factor: 22.113

Review 5.  Defining and Measuring the Affordability of New Medicines: A Systematic Review.

Authors:  Fernando Antoñanzas; Robert Terkola; Paul M Overton; Natalie Shalet; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2017-08       Impact factor: 4.981

6.  A microfluidic platform for functional testing of cancer drugs on intact tumor slices.

Authors:  A D Rodriguez; L F Horowitz; K Castro; H Kenerson; N Bhattacharjee; G Gandhe; A Raman; R J Monnat; R Yeung; R C Rostomily; A Folch
Journal:  Lab Chip       Date:  2020-04-09       Impact factor: 6.799

7.  Repurposing itraconazole as an anticancer agent.

Authors:  Hiroshi Tsubamoto; Tomoko Ueda; Kayo Inoue; Kazuko Sakata; Hiroaki Shibahara; Takashi Sonoda
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

Review 8.  Review of Current Policy Strategies to Reduce US Cancer Drug Costs.

Authors:  Angela K Green; Jennifer A Ohn; Peter B Bach
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

Review 9.  Economic Impact of Oral Therapies for Chronic Lymphocytic Leukemia-the Burden of Novelty.

Authors:  Talal Hilal; Jeffrey A Betcher; Jose F Leis
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

10.  Project ECHO Cancer Initiative: a Tool to Improve Care and Increase Capacity Along the Continuum of Cancer Care.

Authors:  Melissa Lopez Varon; Ellen Baker; Emily Byers; Lucca Cirolia; Oliver Bogler; Matthew Bouchonville; Kathleen Schmeler; Roopa Hariprasad; C S Pramesh; Sanjeev Arora
Journal:  J Cancer Educ       Date:  2021-07-22       Impact factor: 2.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.